{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:07:23Z","timestamp":1793390843312,"version":"4.5.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>We performed an extensive meta-analysis to compare hormone levels and metabolic attributes between obese PCOS (OP) and lean PCOS. The main outcome of the study was the differences in critical clinical parameters, including luteinizing hormone (LH), follicle-stimulating hormone (FSH), low-density lipoprotein (LDL) cholesterol levels, systolic and diastolic blood pressures (BPs), and fasting blood sugar (FBS) levels between lean and OP patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The present systematic review and meta-analysis was conducted in line with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines and the protocol of this study was prospectively registered on PROSPERO (Registration No. CRD420251039530) to minimize reporting bias and enhance transparency. Briefly, a comprehensive search was performed on the PubMed, ISI Web of Science, Embase and Cochrane Central Register of Controlled Trials from inception to Apr. 1, 2025, in any language, with the exclusion of abstract-only publications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Seventy-three studies were analyzed. There were marked differences in metabolic indicators between the two groups. Lean PCOS participants had slightly lower levels of diastolic (SMD \u22120.56, 95% CI \u22120.79 to \u22120.33, p &amp;lt; 0.01) and systolic (SMD \u22120.58, 95% CI \u22120.80 to \u22120.36, p &amp;lt; 0.0003) BP relative to individuals with obese PCOS. They had lower levels of LDL (SMD \u22120.49, 95% CI \u22120.60 to \u22120.38, p &amp;lt; 0.01) and triglycerides (SMD \u22120.72, 95% CI \u22120.85 to \u22120.59, p &amp;lt; 0.01) than obese PCOS participants. The LH\/FSH ratio in lean PCOS patients exceeded that in obese PCOS patients (SMD 0.23, 95% CI 0.07 to 0.40, p &amp;lt; 0.01). Moreover, the homeostasis model assessment of insulin resistance (HOMA-IR) was higher in obese PCOS patients (SMD -0.88, 95% CI -1.03 to -0.72, p &amp;lt; 0.01). However, there were no significant differences in anti-M\u00fcllerian hormone (AMH) level between the two groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This meta-analysis provides valuable information regarding the profile of metabolic and endocrine characteristics between lean and obese PCOS patients. The specific treatment approach should be customized to each patient\u2019s symptoms, fertility needs, and overall health. Further research is advocated to investigate the underlying mechanisms and to develop more targeted treatment strategies for different subgroups of PCOS patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1680685","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T04:16:38Z","timestamp":1760415398000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Analyzing and evaluating the metabolic and endocrine characteristics between lean and obese patients with polycystic ovary syndrome: a systemic review and meta-analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Caiyu","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2147\/clep.S37559","article-title":"Epidemiology, diagnosis, and management of polycystic ovary syndrome","author":"Sirmans","year":"2013","journal-title":"Clin Epidemiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/ipm.2024.56","article-title":"A prospective study of antenatal anxiety and depression in pregnant women with polycystic ovary syndrome","author":"Floyd","year":"2024","journal-title":"Irish J psychol Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dms030","article-title":"Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"18","author":"Lim","year":"2012","journal-title":"Hum Reprod Update"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae488","article-title":"The association between obesity and polycystic ovary syndrome: an epidemiologic study of observational data","volume":"109","author":"Amiri","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpu251","article-title":"Hypertension in reproductive-aged women with polycystic ovary syndrome and association with obesity","volume":"28","author":"Joham","year":"2015","journal-title":"Am J Hypertension"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1080\/01443615.2017.1318840","article-title":"Metabolic effect of obesity on polycystic ovary syndrome in adolescents: a meta-analysis","volume":"37","author":"Li","year":"2017","journal-title":"J Obstetrics Gynaecology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.103011","article-title":"Polycystic ovary syndrome: Is obesity a sine qua non? A clinical, hormonal, and metabolic assessment in relation to body mass index","author":"Prakash","year":"2012","journal-title":"Indian J Endocrinol Metab 16"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-018-0371-5","article-title":"Lean polycystic ovary syndrome (PCOS): an evidence-based practical approach","volume":"17","author":"Toosy","year":"2018","journal-title":"J Diabetes Metab Disord"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocrine Rev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1210\/en.2003-1336","article-title":"Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans","volume":"145","author":"Fain","year":"2004","journal-title":"Endocrinology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.107.151092","article-title":"Metabolic syndrome pandemic, arteriosclerosis","volume":"28","author":"Grundy","year":"2008","journal-title":"Thrombosis Vasc Biol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2012.683082","article-title":"Mediators of chronic inflammation in polycystic ovarian syndrome","volume":"28","author":"Deligeoroglou","year":"2012","journal-title":"Gynecological Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"8229","DOI":"10.1038\/s41598-024-58064-010.1038\/s41598-024-58064-0","article-title":"Mechanism of elevated LH\/FSH ratio in lean PCOS revisited: a path analysis","volume":"14","author":"Pratama","year":"2024","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26094121","article-title":"Autoantibodies targeting the hypothalamic-pituitary-ovarian axis in polycystic ovary syndrome: emerging key players in pathogenesis","volume":"26","author":"Akpang","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(07)61345-2","article-title":"Polycystic ovary syndrome","volume":"370","author":"Norman","year":"2007","journal-title":"Lancet"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.12247","article-title":"Elevated serum levels of anti-M\u00fcllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome","volume":"92","author":"Sahmay","year":"2013","journal-title":"Acta Obstetricia Gynecologica Scandinavica"},{"key":"B19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertility Sterility"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4103\/jhrs.JHRS_77_17","article-title":"Debates regarding lean patients with polycystic ovary syndrome: A narrative review","volume":"10","author":"Goyal","year":"2017","journal-title":"J Hum Reprod Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/19396368.2017.1410591","article-title":"Sex hormone binding globulin - an important biomarker for predicting PCOS risk: A systematic review and meta-analysis","volume":"64","author":"Deswal","year":"2017","journal-title":"Syst Biol Reprod Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1177\/03000605211016672","article-title":"Endocrinological and metabolic characteristics in patients who are non-obese and have polycystic ovary syndrome and different types of a family history of type 2 diabetes mellitus","volume":"49","author":"Wang","year":"2021","journal-title":"J Int Med Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1530\/eje-13-0039","article-title":"The clinical significance and primary determinants of hirsutism in patients with polycystic ovary syndrome","volume":"168","author":"Panidis","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.7570\/jomes24035","article-title":"Obesity and polycystic ovary syndrome","volume":"33","author":"Kim","year":"2024","journal-title":"J Obes Metab Syndrome"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmg044","article-title":"Ultrasound assessment of the polycystic ovary: international consensus definitions","volume":"9","author":"Balen","year":"2003","journal-title":"Hum Reprod Update"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1055\/a-1880-1264","article-title":"Early Clinical, Biochemical and radiological features in obese and non-obese young women with polycystic ovarian syndrome: A comparative study","volume":"54","author":"Kumar","year":"2022","journal-title":"Hormone Metab Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12102313","article-title":"Comparing lean and obese PCOS in different PCOS phenotypes: evidence that the body weight is more important than the rotterdam phenotype in influencing the metabolic status","volume":"12","author":"Carmina","year":"2022","journal-title":"Diagnostics"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_1425_23","article-title":"Understanding metabolic patterns in polycystic ovary syndrome: Comparing lean and obese women at a family medicine clinic","volume":"13","author":"Arunachalam","year":"2024","journal-title":"J Family Med Primary Care"},{"key":"B30","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jsps.2016.12.001","article-title":"Ovulation induction by metformin among obese versus non-obese women with polycystic ovary syndrome","volume":"25","author":"Al-Ruthia","year":"2017","journal-title":"Saudi Pharm J"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1680685\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T04:16:39Z","timestamp":1760415399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1680685\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":30,"alternative-id":["10.3389\/fendo.2025.1680685"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1680685","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"article-number":"1680685"}}